HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaginal powder use results in 50% increased risk for ovarian cancer, study suggests.

This article was originally published in The Rose Sheet

Executive Summary

VAGINAL POWDER DUSTING, DEODORANT SPRAY "MODEST" EFFECT ON OVARIAN CANCER found by a study published in the March 3 issue of the American Journal of Epidemiology. "Our results suggest that a history of perineal dusting or use of genital deodorant sprays has a modest influence on the development of epithelial ovarian tumors," authors Linda Cook, Mary Kamb and Noel Weiss, University of Washington, report.
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS003898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel